The Effects of L-theanine Supplementation on the Outcomes of Patients with Mental Disorders: a Systematic Review

Overview

Journal BMC Psychiatry

Publisher Biomed Central

Specialty Psychiatry

Date 2024 Dec 5

PMID 39633316

Authors

Reza Moshfeghinia

Erfan Sanaei

Sara Mostafavi

Kasra Assadian

Ali Sanaei

Getinet Ayano

Affiliations

Soon will be listed here.

Abstract

Background: When utilized as an adjunct with antidepressants, antipsychotics, and other psychopharmacological drugs, certain amino acids, such as L-Theanine (LT), have shown potential effectiveness in enhancing the symptomatic outcomes of patients with mental disorders. Despite this, there is a lack of previous systematic reviews examining these associations. Therefore, we conducted a systematic review of randomized controlled trials examining these relationships.

Methods: A comprehensive systematic review was conducted, scouring six electronic databases (PubMed, Scopus, PsycINFO, Web of Science, CINAHL Complete, and Cochrane) from their inception up to June 2023, specifically focusing on randomized controlled trials that investigated the effects of LT supplementation on the outcomes of patients with mental health disorders. The Cochrane Risk of Bias Tool for Randomized Trials was employed to assess the quality of the included studies.

Results: Among the 419 publications identified, 11 studies from six countries - Israel, Iran, the USA, Japan, Australia, and Italy - were included in the final analysis. These studies covered a range of mental disorders, including schizophrenia, Attention-Deficit/Hyperactivity Disorder (ADHD), Obsessive-Compulsive Disorder (OCD), Major Depressive Disorder (MDD), sleep disorders, Generalized Anxiety Disorder (GAD), and Tourette syndrome. The findings demonstrated that LT supplementation reduced psychiatric symptoms more effectively than control conditions in individuals with schizophrenia, anxiety disorders, and ADHD.

Conclusions: The findings from this systematic review suggest that LT supplementation significantly reduced psychiatric symptoms more effectively than control conditions in individuals with schizophrenia, anxiety disorders, and ADHD. However, further studies are essential to validate these findings, deepen the understanding of the observed effects, and explore the mechanisms underlying these associations.

References

Dramard V, Kern L, Hofmans J, Reme C, Nicolas C, Chala V . Effect of l-theanine tablets in reducing stress-related emotional signs in cats: an open-label field study. Ir Vet J. 2018; 71:21. PMC: 6178259. DOI: 10.1186/s13620-018-0130-4. View

Lu K, Gray M, Oliver C, Liley D, Harrison B, Bartholomeusz C . The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. Hum Psychopharmacol. 2004; 19(7):457-65. DOI: 10.1002/hup.611. View

Lopes Sakamoto F, Metzker Pereira Ribeiro R, Bueno A, Santos H . Psychotropic effects of -theanine and its clinical properties: From the management of anxiety and stress to a potential use in schizophrenia. Pharmacol Res. 2019; 147:104395. DOI: 10.1016/j.phrs.2019.104395. View

Imafuku F, Yamamoto K, Tanaka E, Aoki R, Nishino S . Analysis of the Effects of Known Sleep-Support Supplements in Relation to Life Habits, Sleep Conditions, and Sleep Problems. Nutrients. 2023; 15(10). PMC: 10220724. DOI: 10.3390/nu15102377. View

Tamano H, Fukura K, Suzuki M, Sakamoto K, Yokogoshi H, Takeda A . Preventive effect of theanine intake on stress-induced impairments of hippocamapal long-term potentiation and recognition memory. Brain Res Bull. 2013; 95:1-6. DOI: 10.1016/j.brainresbull.2013.02.005. View

Moulin M, Crowley D, Xiong L, Guthrie N, Lewis E . Safety and Efficacy of AlphaWave L-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial. Neurol Ther. 2024; 13(4):1135-1153. PMC: 11263523. DOI: 10.1007/s40120-024-00624-7. View

Teschke R, Zhang L, Melzer L, Schulze J, Eickhoff A . Green tea extract and the risk of drug-induced liver injury. Expert Opin Drug Metab Toxicol. 2014; 10(12):1663-76. DOI: 10.1517/17425255.2014.971011. View

Yokogoshi H, Kobayashi M, Mochizuki M, Terashima T . Effect of theanine, r-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res. 1998; 23(5):667-73. DOI: 10.1023/a:1022490806093. View

Muench J, Hamer A . Adverse effects of antipsychotic medications. Am Fam Physician. 2010; 81(5):617-22. View

10.

Wu K, Yao J, Boring D . Green tea extract-induced lethal toxicity in fasted but not in nonfasted dogs. Int J Toxicol. 2010; 30(1):19-20. DOI: 10.1177/1091581810387445. View

11.

Alcazar A, Ballesteros O, Jurado J, Pablos F, Martin M, Vilches J . Differentiation of green, white, black, Oolong, and Pu-erh teas according to their free amino acids content. J Agric Food Chem. 2007; 55(15):5960-5. DOI: 10.1021/jf070601a. View

12.

Edinoff A, Nix C, Hollier J, Sagrera C, Delacroix B, Abubakar T . Benzodiazepines: Uses, Dangers, and Clinical Considerations. Neurol Int. 2021; 13(4):594-607. PMC: 8629021. DOI: 10.3390/neurolint13040059. View

13.

Shamabadi A, Kafi F, Arab Bafrani M, Asadigandomani H, A Basti F, Akhondzadeh S . l-theanine adjunct to sertraline for major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial. J Affect Disord. 2023; 333:38-43. DOI: 10.1016/j.jad.2023.04.029. View

14.

Kardashev A, Ratner Y, Ritsner M . Add-On Pregnenolone with L-Theanine to Antipsychotic Therapy Relieves Negative and Anxiety Symptoms of Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Clin Schizophr Relat Psychoses. 2015; 12(1):31-41. DOI: 10.3371/CSRP.KARA.070415. View

15.

Evans M, McDonald A, Xiong L, Crowley D, Guthrie N . A Randomized, Triple-Blind, Placebo-Controlled, Crossover Study to Investigate the Efficacy of a Single Dose of AlphaWave L-Theanine on Stress in a Healthy Adult Population. Neurol Ther. 2021; 10(2):1061-1078. PMC: 8475422. DOI: 10.1007/s40120-021-00284-x. View

16.

Nathan P, Lu K, Gray M, Oliver C . The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent. J Herb Pharmacother. 2006; 6(2):21-30. View

17.

Brisch R, Saniotis A, Wolf R, Bielau H, Bernstein H, Steiner J . The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry. 2014; 5:47. PMC: 4032934. DOI: 10.3389/fpsyt.2014.00047. View

18.

Rizzo R, Prato A, Scerbo M, Saia F, Barone R, Curatolo P . Use of Nutritional Supplements Based on L-Theanine and Vitamin B6 in Children with Tourette Syndrome, with Anxiety Disorders: A Pilot Study. Nutrients. 2022; 14(4). PMC: 8875106. DOI: 10.3390/nu14040852. View

19.

Sarris J, Byrne G, Cribb L, Oliver G, Murphy J, Macdonald P . L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial. J Psychiatr Res. 2018; 110:31-37. DOI: 10.1016/j.jpsychires.2018.12.014. View

20.

Williams J, McKune A, Georgousopoulou E, Kellett J, DCunha N, Sergi D . The Effect of L-Theanine Incorporated in a Functional Food Product (Mango Sorbet) on Physiological Responses in Healthy Males: A Pilot Randomised Controlled Trial. Foods. 2020; 9(3). PMC: 7142516. DOI: 10.3390/foods9030371. View